Prostate Cancer: Treatment
Treatment options vary depending on the age of the patient, his physical condition, and the aggressiveness of the disease.
Recent advances in the treatment of prostate cancer have raised the ten-year survival rate from 67 percent to more than 90 percent, nearly eliminating local cancers, and extending the lives of men whose prostate cancer has already spread to other areas of the body.
However, it’s important to recognize that no two prostate cancers are alike. Some tumors are more aggressive and need immediate treatment while others fall into the “indolent” or slow-blooming category and are less likely to cause symptoms or to spread to other parts of the body.
Researchers are now trying to determine, with a higher degree of accuracy, what prostate cancers are the most dangerous and should therefore be treated early and aggressively. Every effort is made to avoid over-treatment of indolent cancers because side effects of radiation and surgery, including loss of sexual function and incontinence, can greatly impact a patient’s quality of life.
Experts at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Medical Center treat prostate cancer with the following approaches: